Ashraf Abdel-Fattah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ashraf Abdel-Fattah has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Khalid Am Attia
3 shared publicationsAhmad A.M. Abo-Serie
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, 11751 Nasr City, Cairo, Egypt
2 shared publicationsAhmad Am Abo-Serie
2 shared publications- Ahmed H. Abdelazim
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al- Azhar University, Cairo, Egypt
2 shared publications Khalid A.M. Attia
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, 11751 Nasr City, Cairo, Egypt
2 shared publicationsNasr M El-Abasawi
2 shared publications
Latest Publications
- Open Access
- 3 January 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (2) , 1085-1093
Potentiometric determination of mebeverine hydrochloride antispasmodic drug based on molecular docking with different ionophores host–guest inclusion as a theoretical study
The scientific community has continued to pay particular attention to potentiometric sensors based on ion-selective membrane sensors as an energy-efficient, easy-to-use method suitable for microfabrication. To this end, potentiometric ion-selective sensors were used as an alternative green analytical instrument. Three distinct sensors relying on various ionophores were built and assessed. A cationic exchanger, tetra phenyl borate, was used in the polyvinyl chloride polymeric plasticized matrix using di octyl phthalate, where α, β, and γ cyclodextrins were utilized as ionophores. A comparative potentiometric analysis was carried out using three ion-selective sensor designs: α, β, and γ cyclodextrins sensors. β-Cyclodextrin significantly reduced the detection limit and improved the discriminative performance of mebeverine hydrochloride (MBV) in the pharmaceutical dosage form over α- and γ-cyclodextrins in the presence of other interfering chemicals. Additionally, a significant connection was made between the practical perspective and a theoretical investigation based on computational research. Nernstian potentiometric results for the optimum sensor were obtained for MBV in the range of concentrations 1.0 × 10−2 to 1.0 × 10−6 M, its slope was −58.70 ± 0.12 mV per decade with lower detection limits 4.50 × 10−7 M. This computational molecular docking investigation clarified that the binding sites and modes were in good agreement with the experiment results. This investigation was applied to expect the interaction between MBV and the proposed sensors to ensure which ionophores were the best for MBV.
- 3 January 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (2) , 1085-1093
Open AccessPotentiometric determination of mebeverine hydrochloride antispasmodic drug based on molecular docking with different ionophores host–guest inclusion as a theoretical study
The scientific community has continued to pay particular attention to potentiometric sensors based on ion-selective membrane sensors as an energy-efficient, easy-to-use method suitable for microfabrication. To this end, potentiometric ion-selective sensors were used as an alternative green analytical instrument. Three distinct sensors relying on various ionophores were built and assessed. A cationic exchanger, tetra phenyl borate, was used in the polyvinyl chloride polymeric plasticized matrix using di octyl phthalate, where α, β, and γ cyclodextrins were utilized as ionophores. A comparative potentiometric analysis was carried out using three ion-selective sensor designs: α, β, and γ cyclodextrins sensors. β-Cyclodextrin significantly reduced the detection limit and improved the discriminative performance of mebeverine hydrochloride (MBV) in the pharmaceutical dosage form over α- and γ-cyclodextrins in the presence of other interfering chemicals. Additionally, a significant connection was made between the practical perspective and a theoretical investigation based on computational research. Nernstian potentiometric results for the optimum sensor were obtained for MBV in the range of concentrations 1.0 × 10−2 to 1.0 × 10−6 M, its slope was −58.70 ± 0.12 mV per decade with lower detection limits 4.50 × 10−7 M. This computational molecular docking investigation clarified that the binding sites and modes were in good agreement with the experiment results. This investigation was applied to expect the interaction between MBV and the proposed sensors to ensure which ionophores were the best for MBV.
- 20 October 2022
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 106 (2) , 490-495
Spectrophotometric Quantitative Analysis of Aspirin and Vonoprazan Fumarate in Recently Approved Fixed-Dose Combination Tablets Using Ratio Spectra Manipulating Tools
Background: Low-dose aspirin (ASP) is prescribed to millions of people around the world as a secondary preventative strategy for the majority of significant cardiovascular events; however, it carries a substantial risk of gastric ulcer and bleeding. Cabpirin® tablets, which include low-dose ASP and vonoprazan fumarate (VON), are approved in Japan for the treatment of acid-related diseases in patients who require a low dose of ASP but are at risk of ASP-associated gastric ulcers.Objective: This paper describes the first published quantitative analytical approaches for the determination of ASP and VON.Method: The normal ultraviolet absorption spectra of ASP and vonoprazan overlap significantly. The ratio spectra of the studied drugs were created and manipulated by ratio difference (RD) and first derivative of ratio spectra approaches. In the RD approach, the differences in the amplitude values between 229 and 283 nm enabled the quantitative analysis of ASP, and the differences in the amplitude values between 255 and 212 nm enabled the quantitative analysis of vonoprazan. In the first derivative of the ratio spectra approach, the created ratio spectra of each drug were transformed to the first-order derivative. ASP could be determined selectively at 237.40 nm without interference from vonoprazan. Moreover, vonoprazan could be determined selectively at 244 nm without interference from ASP.Results: The applied approaches were validated according to the ICH guideline, with good results. Linear correlations were obtained for ASP and vonoprazan over concentration ranges of 2–25 and 1–10 µg/mL, respectively.Conclusions: The described methods were optimized, validated, and applied for determination of the studied drugs in the synthetic mixtures and in pharmaceutical tablets without interferences.Highlights: Two spectrophotometric ratio spectra manipulating approaches were developed for the determination of the ASP and vonoprazan in their pharmaceutical combination tablets.
- 20 October 2022
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 106 (2) , 490-495
Spectrophotometric Quantitative Analysis of Aspirin and Vonoprazan Fumarate in Recently Approved Fixed-Dose Combination Tablets Using Ratio Spectra Manipulating Tools
Background: Low-dose aspirin (ASP) is prescribed to millions of people around the world as a secondary preventative strategy for the majority of significant cardiovascular events; however, it carries a substantial risk of gastric ulcer and bleeding. Cabpirin® tablets, which include low-dose ASP and vonoprazan fumarate (VON), are approved in Japan for the treatment of acid-related diseases in patients who require a low dose of ASP but are at risk of ASP-associated gastric ulcers.Objective: This paper describes the first published quantitative analytical approaches for the determination of ASP and VON.Method: The normal ultraviolet absorption spectra of ASP and vonoprazan overlap significantly. The ratio spectra of the studied drugs were created and manipulated by ratio difference (RD) and first derivative of ratio spectra approaches. In the RD approach, the differences in the amplitude values between 229 and 283 nm enabled the quantitative analysis of ASP, and the differences in the amplitude values between 255 and 212 nm enabled the quantitative analysis of vonoprazan. In the first derivative of the ratio spectra approach, the created ratio spectra of each drug were transformed to the first-order derivative. ASP could be determined selectively at 237.40 nm without interference from vonoprazan. Moreover, vonoprazan could be determined selectively at 244 nm without interference from ASP.Results: The applied approaches were validated according to the ICH guideline, with good results. Linear correlations were obtained for ASP and vonoprazan over concentration ranges of 2–25 and 1–10 µg/mL, respectively.Conclusions: The described methods were optimized, validated, and applied for determination of the studied drugs in the synthetic mixtures and in pharmaceutical tablets without interferences.Highlights: Two spectrophotometric ratio spectra manipulating approaches were developed for the determination of the ASP and vonoprazan in their pharmaceutical combination tablets.
- 2 May 2022
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 105 (5) , 1479-1483
Quantitative Spectrophotometric Analysis of Celecoxib and Tramadol in Their Multimodal Analgesia Combination Tablets
Background: Pain is a global, complex health problem that includes physical, emotional, and social components. The pain management process has many goals, including patient satisfaction, reducing clinical complications, and lowering costs. The physician describes pain medications in terms of the proven cause and classification of the severity of the pain. The combination of celecoxib and tramadol was recently approved by the Food and Drug Administration (FDA) in October 2021 for the treatment of acute pain in adults. Objective: This paper presents the first published quantitative analytical methods for celecoxib and tramadol. Methods: The UV absorption spectra of celecoxib and tramadol showed strong overlap. Mathematical simultaneous equation and ratio difference methods were developed to resolve the spectral overlap and quantify the drugs in the combination mixture. In the simultaneous equation method, the absorbance and absorptivity values at 252 and 217 nm were used to construct two mathematical equations that were used for the simultaneous mathematical quantification of the above drugs. The mathematical manipulation of the ratio difference based on the calculation of the differences in the amplitude values between 250 and 280 nm enabled the quantitative analysis of celecoxib, and the differences in the amplitude values between 221 and 272 nm enabled the quantitative analysis of tramadol. Results: The proposed methods were successfully applied to the selective quantitative analysis of celecoxib and tramadol in the synthetic mixtures and in the pharmaceutical tablets without interference from the tablet additives. Conclusions: The applied methods demonstrated good linearity in the concentration range of 1–20 µg/mL and 3–45 µg/mL for celecoxib and tramadol, respectively, with acceptable accuracy and precision. The methods were found to be sensitive with LOD values of 0.183 µg/mL and 0.626 µg/mL for celecoxib and tramadol, respectively, in simultaneous equation method and of 0.275 µg/mL and 0.772 µg/mL for celecoxib and tramadol, respectively, in ratio difference method. Highlights: The first established simple and validated UV spectrophotometric methods were described for concurrent quantification of the celecoxib and tramadol in their recently approved pharmaceutical formulation.
- 2 May 2022
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 105 (5) , 1479-1483
Quantitative Spectrophotometric Analysis of Celecoxib and Tramadol in Their Multimodal Analgesia Combination Tablets
Background: Pain is a global, complex health problem that includes physical, emotional, and social components. The pain management process has many goals, including patient satisfaction, reducing clinical complications, and lowering costs. The physician describes pain medications in terms of the proven cause and classification of the severity of the pain. The combination of celecoxib and tramadol was recently approved by the Food and Drug Administration (FDA) in October 2021 for the treatment of acute pain in adults. Objective: This paper presents the first published quantitative analytical methods for celecoxib and tramadol. Methods: The UV absorption spectra of celecoxib and tramadol showed strong overlap. Mathematical simultaneous equation and ratio difference methods were developed to resolve the spectral overlap and quantify the drugs in the combination mixture. In the simultaneous equation method, the absorbance and absorptivity values at 252 and 217 nm were used to construct two mathematical equations that were used for the simultaneous mathematical quantification of the above drugs. The mathematical manipulation of the ratio difference based on the calculation of the differences in the amplitude values between 250 and 280 nm enabled the quantitative analysis of celecoxib, and the differences in the amplitude values between 221 and 272 nm enabled the quantitative analysis of tramadol. Results: The proposed methods were successfully applied to the selective quantitative analysis of celecoxib and tramadol in the synthetic mixtures and in the pharmaceutical tablets without interference from the tablet additives. Conclusions: The applied methods demonstrated good linearity in the concentration range of 1–20 µg/mL and 3–45 µg/mL for celecoxib and tramadol, respectively, with acceptable accuracy and precision. The methods were found to be sensitive with LOD values of 0.183 µg/mL and 0.626 µg/mL for celecoxib and tramadol, respectively, in simultaneous equation method and of 0.275 µg/mL and 0.772 µg/mL for celecoxib and tramadol, respectively, in ratio difference method. Highlights: The first established simple and validated UV spectrophotometric methods were described for concurrent quantification of the celecoxib and tramadol in their recently approved pharmaceutical formulation.
- 12 June 2018
- Published by Egyptian Knowledge Bank in Journal of Advanced Pharmacy Research
Densitometric Determination of Ezetimibe in the Presence of its Alkaline Degradation Product
A simple, accurate, selective and sensitive densitometric method was developed for the determination of ezetimibe in the presence of its alkaline degradation product. TLC-densitometric separation of ezetimibe from its degradation producte was carried out on silica gel plates using ethyl acetate: n-hexane (2: 1 v/v) as a developing system. This method depends on quantitative densitometric evaluation of ezetimibe at 230 nm over a concentration range of 1 – 8 µg/spot. Ezetimibe and its alkaline degradation product were resolved with Rf values of 0.49 and 0.68 respectively. The proposed method has been successfully applied to the analysis of ezetimibe in pharmaceutical dosage form without interference from additives and the results were statistically compared with the reported method.
- 12 June 2018
- Published by Egyptian Knowledge Bank in Journal of Advanced Pharmacy Research
Densitometric Determination of Ezetimibe in the Presence of its Alkaline Degradation Product
A simple, accurate, selective and sensitive densitometric method was developed for the determination of ezetimibe in the presence of its alkaline degradation product. TLC-densitometric separation of ezetimibe from its degradation producte was carried out on silica gel plates using ethyl acetate: n-hexane (2: 1 v/v) as a developing system. This method depends on quantitative densitometric evaluation of ezetimibe at 230 nm over a concentration range of 1 – 8 µg/spot. Ezetimibe and its alkaline degradation product were resolved with Rf values of 0.49 and 0.68 respectively. The proposed method has been successfully applied to the analysis of ezetimibe in pharmaceutical dosage form without interference from additives and the results were statistically compared with the reported method.
- Open Access
- 16 March 2018
- Published by MedCrave Group Kft. in Journal of Analytical & Pharmaceutical Research
- Vol. 7 (2) , 1
Manipulation of different ratio dependent approaches for determination of pravastatin in the presence of pioglitazone in pharmaceutical preparation
- 16 March 2018
- Published by MedCrave Group Kft. in Journal of Analytical & Pharmaceutical Research
- Vol. 7 (2) , 1
Open AccessManipulation of different ratio dependent approaches for determination of pravastatin in the presence of pioglitazone in pharmaceutical preparation
- Open Access
- 9 March 2018
- Published by Madridge Publishers, LLC in Madridge Journal of Analytical Sciences and Instrumentation
- Vol. 3 (1) , 56-61
Manipulation of Different ratio Dependent approaches for Determination of Pravastatin in the presence of Pioglitazone in Pharmaceutical Preparation
- 9 March 2018
- Published by Madridge Publishers, LLC in Madridge Journal of Analytical Sciences and Instrumentation
- Vol. 3 (1) , 56-61
Open AccessManipulation of Different ratio Dependent approaches for Determination of Pravastatin in the presence of Pioglitazone in Pharmaceutical Preparation
- 2 January 2018
- Published by Taylor & Francis in Analytical Chemistry Letters
- Vol. 8 (1) , 46-53
Simultaneous Determination of Rosuvastatin and Propranolol by HPLC in Pharmaceutical Dosage Form
Rosuvatatine calcium and propranolol hydrochloride have been already presented in a combined pharmaceutical preparation for treatment of the patients suffering from hyperchloestrolemia with hypertension disease. Hence, a separating technique should be applied for the determination of both drugs. Chromatographic simultaneous determination has been applied for estimating rosuvastatin calcium and propranolol hydrochloride in the combined form. An isocratic separation was carried out on BDS Hypersil C18 (250×4.6 mm, 5 μm particle size) reversed phase column with a mobile phase containing methanol: acetonitrile: buffer (0.05 M sodium acetate, pH adjusted to 4.0 using acetic acid) (60:35:5; v/v/v). The flow rate was 1 mL/min and UV detection was set at 231 nm. The linear regression analysis of the calibration graphs showed a good linear relationship for both drugs over a concentration range of 5-25 μg/ml. The method was validated according to ICH guidelines. The proposed method has been found to be accurate, reproducible feasible, and specific for simultaneous analysis of both drugs in both bulk and commercial dosage form.
- 2 January 2018
- Published by Taylor & Francis in Analytical Chemistry Letters
- Vol. 8 (1) , 46-53
Simultaneous Determination of Rosuvastatin and Propranolol by HPLC in Pharmaceutical Dosage Form
Rosuvatatine calcium and propranolol hydrochloride have been already presented in a combined pharmaceutical preparation for treatment of the patients suffering from hyperchloestrolemia with hypertension disease. Hence, a separating technique should be applied for the determination of both drugs. Chromatographic simultaneous determination has been applied for estimating rosuvastatin calcium and propranolol hydrochloride in the combined form. An isocratic separation was carried out on BDS Hypersil C18 (250×4.6 mm, 5 μm particle size) reversed phase column with a mobile phase containing methanol: acetonitrile: buffer (0.05 M sodium acetate, pH adjusted to 4.0 using acetic acid) (60:35:5; v/v/v). The flow rate was 1 mL/min and UV detection was set at 231 nm. The linear regression analysis of the calibration graphs showed a good linear relationship for both drugs over a concentration range of 5-25 μg/ml. The method was validated according to ICH guidelines. The proposed method has been found to be accurate, reproducible feasible, and specific for simultaneous analysis of both drugs in both bulk and commercial dosage form.
- Open Access
- 23 August 2016
- Published by MedCrave Group Kft. in Journal of Analytical & Pharmaceutical Research
- Vol. 3 (1)
Bivariate and Multivariate Spectrophotometric Methods for Determination of Ezetimibe with Kinetic Study of Its Alkaline Degradation
- 23 August 2016
- Published by MedCrave Group Kft. in Journal of Analytical & Pharmaceutical Research
- Vol. 3 (1)
Open AccessBivariate and Multivariate Spectrophotometric Methods for Determination of Ezetimibe with Kinetic Study of Its Alkaline Degradation
- 27 September 2007
- Published by Wiley in ChemInform
- Vol. 38 (42)
Benzotriazole‐Mediated Alkoxyalkylation and Acyloxyalkylation.
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
- 27 September 2007
- Published by Wiley in ChemInform
- Vol. 38 (42)
Benzotriazole‐Mediated Alkoxyalkylation and Acyloxyalkylation.
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.